AVAdi V. GundlapalliJan 8, 2025New paperautoPaperAnti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022PLoS ONE · 2025 · Anna Bratcher, Jefferson M Jones, William A Meyer et al.